Icono tienda


Publicado por

Understanding disease modifiers and heterogeneity in Alzheimer’s                                    disease – UndoAD – Colombo-German Consortium

Sponsored by                                                                                                         
UndoAD- Consortium

The main aim of the UndoAD consortium is to identify disease modifiers to explain the heterogeneity found in Alzheimer’s disease. This will be achieved in the framework of a BMBF-supported Consortium which will establish standardized laboratory techniques and launch a common educational platform.

Partners of UndoAD are:

Prof. Dr. med. Markus Glatzel Dr. med. Diego Sepulveda FallaInstitut für Neuropathologie am Universitätsklinikum Hamburg-Eppendorf (https://www.uke.de/english/departments-institutes/institutes/neuropathology/research/index.html) 

Prof. Dr. med. Inga Zerr, Leiterin der translationalen Demenzforschung am Deutschen Zentrum für Neurodegenerative Erkrankungen in Göttingen (TDG) (http://cjd-goettingen.de/)

Prof. Dr. med. F. Lopera / Prof. Dr. med. Andres Villegas / Prof. Dr. M. Arcos-Burgos, Neurosciences-Group of Antioquia, Universidad de Antioquia, Medellín (www.gna.org.co).

The aims of UndoAD are:

  • To establish a research network for data exchange and integration between the partners, including anonymized data resulted from clinical follow up, neuropathological analysis and biochemical studies of Alzheimer’s disease patients.
  • To develop long-term joint laboratory facilities (GNA Brain Bank) in a work-sharing approach, involving tele neuropathological diagnosis and support by the Institute of Neuropathology at UKE.
  • To develop third-party funded projects aimed to study disease heterogeneity in Alzheimer’s disease (see for instance NIH grant 1RF1NS110048-01).
  • To organize an annual Summer School in order to socialize the UndoAD joint effort on an international level.

UndoAD – International Summer Schools

2019 – 2nd International Summer School of Dementia Diagnosis and Pathology Medellin, Colombia and 1st Latin-American Brain Banks Seminar – TBA

2018 – 1st International Summer School of Dementia Diagnosis and Pathology Medellin, Colombia, September 12th and 13th.


  • Francisco Lopera, University of Antioquia.
  • Yakeel Quiroz, Massachusetts General Hospital.
  • Andrés Villegas, University of Antioquia.
  • Patricia Cardona, University of Antioquia.
  • Diego Sepúlveda-Falla, UKE Hamburg., Germany.
  • Kenneth Kosik, University of California, Santa Barbara.
  • Markus Glatzel, UKE Hamburg, Germany.
  • Inga Zerr, University of Göttingen, Germany.
  • Susanne Krasemann, UKE Hamburg, Germany.
  • Mauricio Arcos-Burgos, University of el Rosario.
  • Elena Becker Barroso, The Lancet Neurology Journal.


No Comments